Age at time of event: 18 years or older.
Device is a combination product.
(b)(4).
Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.
A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.
If there is any further relevant information from that review, a supplemental medwatch will be filed.
(b)(4).
|
It was reported that stent fracture, chest pain and angina occurred.
The target lesion was located in a coronary artery.
A 3.
00x16mm synergy¿ drug-eluting stent was implanted to treat the lesion.
However, a few days later, the patient returned to the hospital due to chest pain and angina.
Coronary angiography revealed that the implanted stent was fractured and was bent inside the vessel.
A non-bsc stent was implanted inside the fractured synergy stent and the patient was discharged home.
No further patient complications were reported.
The physician noted this likely occurred due to the pressure and angle of the vessel.
|